中文
|
English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Home
About Journal
Journal Introduction
Editorial Board
Reviewers
Style of Editorial Department
Advertising Policies
Submission Guideline
Instructions for Authors
Editorial Policies
Open Access Policy
Publishing Ethics
Publication Process Flow
Peer Review Process
Conflict of interest statement
Statement of Human and Animal Rights
Statement of Informed Consent and ethical approval
Data Sharing Policy
Statement of Copyright information
Open Science Identifier (OSID) Recording
Paper Template
Handling method for withdrawal
Journal Online
Online First
Current Issue
Archive
F5000 Articles
Hepatobiliary College
Guide to foreign journals
Industry information
Video Classroom
Guidelines
All Guidelines
Domestic guidelines
Foreign guidelines
Guideline translation
Guideline interpretation
Menu
All
Title
Author
Keyword
Abstract
DOI
Category
Address
Fund
Home
About Journal
Journal Introduction
Editorial Board
Reviewers
Style of Editorial Department
Advertising Policies
Submission Guideline
Instructions for Authors
Editorial Policies
Open Access Policy
Publishing Ethics
Publication Process Flow
Peer Review Process
Conflict of interest statement
Statement of Human and Animal Rights
Statement of Informed Consent and ethical approval
Data Sharing Policy
Statement of Copyright information
Open Science Identifier (OSID) Recording
Paper Template
Handling method for withdrawal
Journal Online
Online First
Current Issue
Archive
F5000 Articles
Hepatobiliary College
Guide to foreign journals
Industry information
Video Classroom
Guidelines
All Guidelines
Domestic guidelines
Foreign guidelines
Guideline translation
Guideline interpretation
PDF
Cite
Share
facebook
twitter
google
linkedin
All
Title
Author
Keyword
Abstract
DOI
Category
Address
Fund
Volume 38
Issue 2
Feb. 2022
Turn off MathJax
Article Contents
References
Article Navigation
>
Journal of Clinical Hepatology
>
2022
>
38(2): 319-319
PDF
( 1389 KB)
Hepatology
|Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway
DOI:
10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2
Published Date:
2022-02-20
Abstract
FullText(HTML)
References
(0)
References
Relative Articles
Relative Articles
[1]
Journal of Gastroenterology and Hepatology
|Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway
[J]. Journal of Clinical Hepatology, 2024, 40(5): 1049-1049.
doi:
10.12449/JCH2405.gwqkjpwzjj4
[2]
Journal of Gastroenterology and Hepatology
|Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis
[J]. Journal of Clinical Hepatology, 2023, 39(11): 2523-2523.
doi:
10.3969/j.issn.1001-5256.2023.11.gwjpwzjj1
[3]
Hepatology Research
|Clinical features of chronic hepatitis B patients with lean nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2023, 39(5): 1171-1171.
doi:
10.3969/j.issn.1001-5256.2023.05.gwjpwzjj3
[4]
Guangyue YANG, Le TAO, Wei ZHANG, Xuling LIU, Wenting MA, Liu WU, Tiantian SUN, Hao JIANG, Cheng LIU.
Mechanism of action of Eupolyphaga steleophaga in improving nonalcoholic steatohepatitis by regulating syndecan 3
[J]. Journal of Clinical Hepatology, 2022, 38(7): 1513-1520.
doi:
10.3969/j.issn.1001-5256.2022.07.012
[5]
Shudi LI, Xinju CHEN, Jiangkai LIU, Zhen WANG, Fei DUAN, Zhuoya YUAN, Lei LIANG, Suling LI.
Signaling pathways involved in the active components of Polygonum cuspidatum in treatment of nonalcoholic fatty liver disease and their interaction
[J]. Journal of Clinical Hepatology, 2022, 38(4): 902-907.
doi:
10.3969/j.issn.1001-5256.2022.04.033
[6]
Hepatology
|Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2022, 38(9): 2039-2039.
doi:
10.3969/j.issn.1001-5256.2022.09.gwjpwzjj3
[7]
Hepatology
| Peroxisome proliferator - activated receptor α promotes liver enlargement and liver regeneration via the YAP-TEAD signaling pathway
[J]. Journal of Clinical Hepatology, 2022, 38(2): 341-341.
doi:
10.3969/j.issn.1001-5256.2022.02.gwjpwzjj3
[8]
Hepatology
|Myeloid cell-specific IL-6 signal alleviates nonalcoholic fatty liver disease-related fibrosis by promoting the release of microRNA-223-enriched exosome
[J]. Journal of Clinical Hepatology, 2022, 38(2): 414-414.
doi:
10.3969/j.issn.1001-5256.2022.02.gwjpwzjj6
[9]
Gege TIAN, Enrui XIA, Suyan ZHANG, Shunzhen ZHAGN, Furong XU.
Research advances in traditional Chinese medicine in improving nonalcoholic steatohepatitis by regulating the Toll-like receptor 4/nuclear factor-kappa B signaling pathway
[J]. Journal of Clinical Hepatology, 2021, 37(12): 2957-2962.
doi:
10.3969/j.issn.1001-5256.2021.12.047
[11]
Xiang Zhao, Yang JinHui.
Role of the OPG/RANKL/RANK signaling pathway in the progression of nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2020, 36(7): 1631-1633.
doi:
10.3969/j.issn.1001-5256.2020.07.040
[13]
Sun TingTing, Li JingTao, Wei HaiLiang, Yan ShuGuang, Li Qian, Guo YingJun, Chang ZhanJie.
Research advances in the role of the TNF-α/NF-κB signaling pathway in the regulation of nonalcoholic fatty liver disease
[J]. Journal of Clinical Hepatology, 2019, 35(9): 2095-2098.
doi:
10.3969/j.issn.1001-5256.2019.09.047
[14]
Yan Hua, Zhang Ying, Wang Huan, Gao YanQiong, Liu GuiSheng, Lei JianYuan.
Chlorogenic acid exerts preventive and therapeutic effects on nonalcoholic fatty liver disease by inhibiting the JNK signaling pathway
[J]. Journal of Clinical Hepatology, 2018, 34(2): 359-363.
doi:
10.3969/j.issn.1001-5256.2018.02.028
[15]
Zhao WenXia, Yan Le, Shao MingYi, Zhang LiHui.
Effect of Huatan Qushi Huoxue prescription on the ADPN/AMPK/ACC signaling pathway in rats with nonalcoholic steatohepatitis
[J]. Journal of Clinical Hepatology, 2017, 33(5): 932-936.
doi:
10.3969/j.issn.1001-5256.2017.05.029
[18]
An BaiQuan, Jiang Man, Xin YongNing, Jiang XiangJun, Liu ZhenSheng, Xuan ShiYing.
Role of Hedgehog signaling pathway in progression of non-alcoholic fatty liver fibrosis
[J]. Journal of Clinical Hepatology, 2015, 31(3): 457-459.
doi:
10.3969/j.issn.1001-5256.2015.03.035
[19]
Song HaiYan, Mao ZhiMin, Yang LiLi, Zhang Li, Ge YingLi, Liu Tao, Liu Ping, Ji Guang.
Mechanism of Dangfei Liganning Capsule attenuating nonalcoholic steatotic hepatitis induced by high-fat diet combined with carbon tetrachloride in rats
[J]. Journal of Clinical Hepatology, 2012, 28(3): 196-200.
[20]
Cai WeiMin.
Endocannabinoid receptors and nonalcoholic steatohepatitis
[J]. Journal of Clinical Hepatology, 2010, 26(2): 149-152.
Supplements
(0)
Cited By
Proportional views
Proportional views
Catalog
通讯作者:
陈斌, bchen63@163.com
1.
沈阳化工大学材料科学与工程学院 沈阳 110142
本站搜索
百度学术搜索
万方数据库搜索
CNKI搜索
Get Citation
PDF
XML
Article Metrics
Article views (
287
)
PDF downloads(
26
)
Cited by(
)
Proportional views
Related
Previous
Next
×
Close
Export File
Citation
Hepatology|Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway[J]. J Clin Hepatol, 2022, 38(2): 319-319. DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2.
Hepatology
|Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway[J].
J Clin Hepatol
, 2022, 38(2): 319-319.
DOI:
10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2.
Format
RIS(for EndNote,Reference Manager,ProCite)
BibTex
Txt
Content
Citation Only
Citation and Abstract
/
DownLoad:
Full-Size Img
PowerPoint
Return
Return